Laura Clague
Insider Reports History
- Location
- Escondido, CA
- Signature
- /s/ Laura Clague by Agnieszka Gallagher, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Laura Clague:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Genasys Inc. | Director | Common Stock | 284,311 | $525,975 | $1.85 | 27 Apr 2022 | Direct |
| Travere Therapeutics, Inc. | Chief Financial Officer | Common Stock | 35,655 | $319,469 | $8.96 | 11 May 2022 | Direct |
| STANDARD BIOTOOLS INC. | Director | Common Stock | 104,791 | $266,169 | $2.54 | 14 Jun 2023 | Direct |
| STANDARD BIOTOOLS INC. | Director | Stock Option (Right to Buy) | 35,380 | $132,321 | $3.74 | 14 Jun 2023 | Direct |
| Genasys Inc. | Director | Common Stock | 2,000 | $3,700 | $1.85 | 27 Apr 2022 | spouse |
| Genasys Inc. | Director | Stock Option | 0 | 27 Apr 2022 | Direct |
Insider Reports Filed by Laura Clague
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 20:41 |
| LAB | STANDARD BIOTOOLS INC. | 15 Jun 2022 | 2 | $0 | 4 | Director | 17 Jun 2022, 18:04 |
| TVTX | Travere Therapeutics, Inc. | 10 May 2022 | 2 | -$47,322 | 4 | Chief Financial Officer | 12 May 2022, 20:45 |
| GNSS | Genasys Inc. | 27 Apr 2022 | 2 | +$66,500 | 4 | Director | 27 Apr 2022, 19:02 |
| GNSS | Genasys Inc. | 15 Mar 2022 | 1 | $0 | 4 | Director | 17 Mar 2022, 15:36 |
| GNSS | Genasys Inc. | 23 Feb 2022 | 3 | +$132 | 4 | Director | 24 Feb 2022, 12:54 |
| TVTX | Travere Therapeutics, Inc. | 31 Jan 2022 | 5 | -$33,921 | 4 | Chief Financial Officer | 02 Feb 2022, 15:17 |
| TVTX | Travere Therapeutics, Inc. | 24 Jan 2022 | 1 | -$51,534 | 4 | Chief Financial Officer | 26 Jan 2022, 15:34 |
| TVTX | Travere Therapeutics, Inc. | 10 Jan 2022 | 2 | -$205,500 | 4 | Chief Financial Officer | 12 Jan 2022, 15:05 |
| TVTX | Travere Therapeutics, Inc. | 13 Aug 2021 | 2 | -$24,085 | 4 | Chief Financial Officer | 17 Aug 2021, 19:34 |
| LAB | FLUIDIGM CORP | 25 May 2021 | 2 | $0 | 4 | Director | 27 May 2021, 17:28 |
| TVTX | Travere Therapeutics, Inc. | 11 May 2021 | 2 | -$77,200 | 4 | Chief Financial Officer | 13 May 2021, 16:07 |